NR2C2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.807200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.352000E-01
Normal-vs-Stage2
2.797800E-01
Normal-vs-Stage3
1.482390E-01
Normal-vs-Stage4
3.299400E-01
Stage1-vs-Stage2
2.310800E-01
Stage1-vs-Stage3
2.404200E-02
Stage1-vs-Stage4
9.178000E-01
Stage2-vs-Stage3
3.315800E-02
Stage2-vs-Stage4
2.588800E-01
Stage3-vs-Stage4
1.688300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.835200E-01
Normal-vs-AfricanAmerican
1.631170E-01
Normal-vs-Asian
1.598310E-02
Caucasian-vs-AfricanAmerican
6.934000E-01
Caucasian-vs-Asian
1.526960E-01
AfricanAmerican-vs-Asian
2.373200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.727000E-01
Normal-vs-Female
2.936800E-01
Male-vs-Female
4.907200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.696600E-01
Normal-vs-Age(41-60Yrs)
3.303400E-01
Normal-vs-Age(61-80Yrs)
2.678000E-01
Normal-vs-Age(81-100Yrs)
2.063600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.978200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.257800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.281600E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.900200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.825650E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.620800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.540400E-01
Normal-vs-Daily Drinker
2.189800E-01
Normal-vs-Weekly Drinker
2.587400E-01
Normal-vs-Occasional Drinker
3.651500E-02
Normal-vs-Social Drinker
1.004980E-01
Non Drinker-vs-Daily Drinker
4.020800E-01
Non Drinker-vs-Weekly Drinker
9.753200E-01
Non Drinker-vs-Occasional Drinker
3.510800E-01
Non Drinker-vs-Social Drinker
9.702400E-02
Daily Drinker-vs-Weekly Drinker
4.556200E-01
Daily Drinker-vs-Occasional Drinker
1.060610E-01
Daily Drinker-vs-Social Drinker
2.543900E-02
Weekly Drinker-vs-Occasional Drinker
4.408400E-01
Weekly Drinker-vs-Social Drinker
1.615350E-01
Occasional Drinker-vs-Social Drinker
4.702600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.398180E-01
Normal-vs-Grade 2
3.230400E-02
Normal-vs-Grade 3
2.446300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.519400E-01
Grade 1-vs-Grade 3
8.860200E-01
Grade 1-vs-Grade 4
1.398180E-01
Grade 2-vs-Grade 3
7.368800E-01
Grade 2-vs-Grade 4
3.230400E-02
Grade 3-vs-Grade 4
2.446300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.414400E-01
Normal-vs-NonDiabetic
2.681400E-01
Diabetic-vs-NonDiabetic
3.668000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.513800E-01
Normal-vs-NoPancreatitis
2.648800E-01
Pancreatitis-vs-NoPancreatitis
7.401800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.717900E-02
Normal-vs-N1
2.783600E-01
N0-vs-N1
7.094800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.183600E-01
Normal-vs-TP53-NonMutant
4.216800E-01
TP53-Mutant-vs-TP53-NonMutant
5.705700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
